Nike Falls 9.6% on Weak Outlook; Synaptics Jumps on $5.7B All-Cash Deal

โดย Investing.com·US·Read original
Summary · why it matters

Nike tumbled 9.6% in premarket trading to $31.79 after the athletic footwear and apparel giant reported mixed fiscal first-quarter 2027 results and issued a weaker-than-expected full-year outlook. Nike reported adjusted earnings of 48 cents per share, topping the 44-cent consensus estimate, but revenue of $11.21 billion missed expectations of $11.35 billion and declined 5% on a currency-neutral basis from a year earlier. Synaptics surged 13.8% in premarket trading after onsemi and Synaptics amended their merger agreement, converting the transaction from an all-stock deal into an all-cash acquisition at $123 per share, valuing Synaptics at about $5.7 billion. The change followed an unsolicited, non-binding proposal from an unnamed strategic party received by Synaptics on Sept. 2, prompting the two companies to renegotiate the deal structure and consideration. Moderna rose 2.2% in premarket trading to $193.15 after Nasdaq confirmed the biotechnology company will be added to the Nasdaq-100 Index effective Oct. 9, replacing Warner Bros. Discovery, while Fair Isaac fell 6.9% after Bloomberg reported the Federal Housing Finance Agency plans to require lenders to use credit data from only two of the three major credit bureaus for mortgages sold to Fannie Mae and Freddie Mac.

Impact on assets 12

Artificial Intelligence± Mixed · 2 stocks
Synaptics Incorporated
SYNA
▲ PositiveCapitalrelevance

Synaptics surged after onsemi amended their merger agreement to an all-cash acquisition at $123 per share, valuing Synaptics at about $5.7B.

Fair Isaac Corporation
FICO
▼ NegativeRegulationrelevance

FHFA plans to require lenders to use only two of the three major credit bureaus for mortgages sold to Fannie Mae and Freddie Mac, threatening Fair Isaac's credit-score business.

Financials▲ · 2 stocks
Cybersecurity & Digital Trust▲ · 2 stocks
Digital Finance & Tokenization▲ · 2 stocks
Consumer Discretionary▼ · 1 stocks
Nike Inc
NKE
▼ NegativeCapitalrelevance

Nike reported mixed fiscal Q1 2027 results with revenue of $11.21B missing estimates and down 5% currency-neutral, plus a weaker-than-expected full-year outlook.

Biotech & Genomic Medicine▲ · 1 stocks
Moderna Inc
MRNA
▲ PositiveCapitalrelevance

Nasdaq confirmed Moderna will be added to the Nasdaq-100 Index effective Oct. 9, replacing Warner Bros. Discovery.

Semiconductors▲ · 1 stocks
ON Semiconductor Corporation
ON
▲ PositiveCapitalrelevance

onsemi amended its merger agreement with Synaptics, converting the deal to an all-cash acquisition at $123 per share valuing Synaptics at about $5.7B.

Communication Services▲ · 1 stocks
© 2026 MarketDXNews